These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34560383)

  • 41. Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options.
    Iocca O; Farcomeni A; Di Rocco A; Di Maio P; Golusinski P; Pardiñas López S; Savo A; Pellini R; Spriano G
    Oral Oncol; 2018 May; 80():40-51. PubMed ID: 29706187
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial.
    Lu W; Wayne PM; Davis RB; Buring JE; Li H; Macklin EA; Lorch JH; Burke E; Haddad TC; Goguen LA; Rosenthal DS; Tishler RB; Posner MR; Haddad RI
    Oncologist; 2016 Dec; 21(12):1522-1529. PubMed ID: 27511906
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
    Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J
    Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Concurrent chemoradiotherapy with cisplatin or cetuximab for locally advanced head and neck squamous cell carcinomas: Does human papilloma virus play a role?
    Ou D; Levy A; Blanchard P; Nguyen F; Garberis I; Casiraghi O; Scoazec JY; Janot F; Temam S; Deutsch E; Tao Y
    Oral Oncol; 2016 Aug; 59():50-57. PubMed ID: 27424182
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cisplatin and radiotherapy with or without erlotinib in locally advanced squamous cell carcinoma of the head and neck: a randomized phase II trial.
    Martins RG; Parvathaneni U; Bauman JE; Sharma AK; Raez LE; Papagikos MA; Yunus F; Kurland BF; Eaton KD; Liao JJ; Mendez E; Futran N; Wang DX; Chai X; Wallace SG; Austin M; Schmidt R; Hayes DN
    J Clin Oncol; 2013 Apr; 31(11):1415-21. PubMed ID: 23460709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of survival of patients with locally advanced head and neck cancer treated in a single center.
    Santos FMD; Viani GA; Pavoni JF
    Braz J Otorhinolaryngol; 2021; 87(1):3-10. PubMed ID: 31395491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concomitant chemoradiation versus radical radiotherapy in advanced squamous cell carcinoma of oropharynx and nasopharynx using weekly cisplatin: a phase II randomized trial.
    Sharma A; Mohanti BK; Thakar A; Bahadur S; Bhasker S
    Ann Oncol; 2010 Nov; 21(11):2272-2277. PubMed ID: 20427350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global quality of life during the acute toxicity phase of multimodality treatment for patients with head and neck cancer: can we identify patients most at risk of profound quality of life decline?
    Tribius S; Reemts E; Prosch C; Raguse M; Petersen C; Kruell A; Singer S; Bergelt C
    Oral Oncol; 2012 Sep; 48(9):898-904. PubMed ID: 22502815
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
    Mesía R; Rivera F; Kawecki A; Rottey S; Hitt R; Kienzer H; Cupissol D; De Raucourt D; Benasso M; Koralewski P; Delord JP; Bokemeyer C; Curran D; Gross A; Vermorken JB
    Ann Oncol; 2010 Oct; 21(10):1967-1973. PubMed ID: 20335368
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality of life following treatment with intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer.
    Cossyleon R; Robinson K; Delfino K; Robbins KT; Rao K
    Support Care Cancer; 2024 Jan; 32(2):93. PubMed ID: 38193937
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparing high-dose cisplatin with cisplatin-based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC).
    Furqan M; Snyders TP; Saqlain MU; Mott SL; Laux D; Snow A; Anderson CM; Watkins JM; Clamon GH
    Cancer Med; 2019 Jun; 8(6):2730-2739. PubMed ID: 30968604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of p16 Status on the Quality-of-Life Experience During Chemoradiation for Locally Advanced Oropharyngeal Cancer: A Substudy of Randomized Trial Trans-Tasman Radiation Oncology Group (TROG) 02.02 (HeadSTART).
    Ringash J; Fisher R; Peters L; Trotti A; O'Sullivan B; Corry J; Kenny L; Nuyts S; Wratten C; Rischin D
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):678-686. PubMed ID: 27209505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.
    Milowsky MI; O'Donnell PH; Hoimes CJ; Petrylak DP; Flaig TW; Moon HH; Friedlander TW; Mar N; McKay RR; Srinivas S; Gravis G; Ramamurthy C; Bupathi M; Bracarda S; Wright P; Hepp Z; Carret AS; Yu Y; Dillon R; Kataria R; Beaumont JL; Purnajo I; Rosenberg JE
    J Clin Oncol; 2024 Apr; 42(12):1403-1414. PubMed ID: 38215355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Randomized phase III study of 2 cisplatin-based chemoradiation regimens in locally advanced head and neck squamous cell carcinoma: impact of changing disease epidemiology on contemporary trial design.
    Rodriguez CP; Adelstein DJ; Rybicki LA; Savvides P; Saxton JP; Koyfman SA; Greskovich JF; Yao M; Scharpf J; Lavertu P; Wood BG; Burkey BB; Lorenz RR; Rezaee RP; Zender CA; Ives DI
    Head Neck; 2015 Nov; 37(11):1583-9. PubMed ID: 24909549
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Feasibility of radiotherapy or chemoradiotherapy after taxane-based induction chemotherapy for nonoperated locally advanced head and neck squamous cell carcinomas.
    Levy A; Blanchard P; Bellefqih S; Brahimi N; Guigay J; Janot F; Temam S; Daly-Schveitzer N; Bourhis J; Tao Y
    Anticancer Drugs; 2014 Nov; 25(10):1220-6. PubMed ID: 25144345
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Randomized Clinical Trial on Reduction of Radiotherapy Dose to the Elective Neck in Head and Neck Squamous Cell Carcinoma: Results on the Quality of Life.
    Deschuymer S; Nevens D; Duprez F; Daisne JF; Voordeckers M; De Neve W; Nuyts S
    Qual Life Res; 2021 Jan; 30(1):117-127. PubMed ID: 32920767
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Weekly Low-Dose Versus Three-Weekly High-Dose Cisplatin for Concurrent Chemoradiation in Locoregionally Advanced Non-Nasopharyngeal Head and Neck Cancer: A Systematic Review and Meta-Analysis of Aggregate Data.
    Szturz P; Wouters K; Kiyota N; Tahara M; Prabhash K; Noronha V; Castro A; Licitra L; Adelstein D; Vermorken JB
    Oncologist; 2017 Sep; 22(9):1056-1066. PubMed ID: 28533474
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quality of Life of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving High-Dose Cisplatin Chemotherapy and Radiotherapy.
    Visacri MB; Ferrari GB; Dias P; Pimentel R; de Souza CM; Costa AP; de Carvalho Pincinato E; Lima CS; Mazzola PG; Moriel P
    South Med J; 2015 Jun; 108(6):343-9. PubMed ID: 26079459
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A phase I study of cabazitaxel in combination with platinum and 5-fluorouracil (PF) in locally advanced squamous cell carcinoma of head and neck (LA-SCCHN).
    Camille N; Rozehnal J; Roy E; Uczkowski D; Olson A; Genden E; Teng M; Bakst R; Gupta V; Posner M; Misiukiewicz K
    Oral Oncol; 2017 Aug; 71():99-104. PubMed ID: 28688700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.